Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys in Baltic Patients with Chronic Hepatitis B
NCT00436163Phase 4Completed
- Sponsor
- Roche
- Start
- Mar 2007
- Primary completion
- May 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 3
01
Overview
A Phase 4 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Roche. Started Mar 2007; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00436163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436163.